Skip to main content

Table 1 Susceptibility of mouse strains to immunization with matrilin-1, as shown by their development of matrilin-1-induced relapsing polychondritis (MIRP)

From: Critical role of the major histocompatibility complex and IL-10 in matrilin-1-induced relapsing polychondritis in mice

Mouse strain

MHC

Gender

n

Incidence of disease (%)

Mean maximum

disease score

Day of onset of

symptoms

QD

H2 q

m

12

92

4.8 ± 0.4a

41 ± 1b

B10.Q

H2 q

m

16

56

2.6 ± 0.7

46 ± 4

B10.Q

H2 q

f

8

25

2.0 ± 0

41 ± 0

C3H.Q

H2 q

m

9

33

3.7 ± 1.2

46 ± 3

DBA/1

H2 q

m

12

50

3.2 ± 0.5

55 ± 8c

Balb/c

H2 d

m

5

0

  

NOD

H2 g7

m

10

0

  

B10.P

H2 p

m

5

40

3.0 ± 1.0

45 ± 0

B10.RIII

H2 r

m

8

25

2.0 ± 0

47 ± 2

B10.V

H2 v

m

5

0

  

B10

H2 b

m

5

0

  

B10.F

H2 f

m

5

0

  

B10.U

H2 u

m

1

0

  
  1. Only affected mice were included in the statistical analysis. aQD mice developed higher mean maximum disease scores than mice from the B10.Q, DBA/1, B10.P, and B10.RIII strains (P < 0.05). bQD mice developed disease symptoms earlier than all other strains (P < 0.05). cDBA/1 mice developed disease symptoms later than all other strains (P < 0.05). f, female; m, male; QD, (B10.Q × DBA/1)F1 mice.